Unveiling the mechanisms of comorbidity of aging and depression: A perspective based on early life stress (ELS)

Acta Pharmaceutica Sinica B · Published 2026-08-01 · DOI 10.1016/j.apsb.2026.07.053

Free full text

Authors (5)

Chenli Lin, Sen Zhang, Qing Li, Zhengtang Qi, Weina Liu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lin, C., Zhang, S., Li, Q., et al. (2026). Unveiling the mechanisms of comorbidity of aging and depression: A perspective based on early life stress (ELS). Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.07.053

Related articles

• Inflammation in atherosclerosis: drivers, mechanisms and therapies · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Modulating macrophage efferocytosis: Drug delivery strategies for enhancement, mimicry, and inhibition · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Editor Profiles: Guest Editors of the Special Column on Machine Learning in Drug Discovery · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Targeting senescent cells with dipeptidyl peptidase 4–CAR–NK cells alleviates liver fibrosis and reverses metabolic dysfunction · Acta Pharmaceutica Sinica B · 2026 · Same journal
• SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1 · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Nano-drug delivery systems of natural products in cardiovascular therapy: From mechanistic insights to precision targeting · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Reaction-aware molecular representation learning: Toward generalizable artificial intelligence for enzymatic catalysis · Acta Pharmaceutica Sinica B · 2026 · Same journal
• Neuroprotection by YZG-331 in postoperative cognitive dysfunction via Mg2+-dependent blockade of NMDA receptors · Acta Pharmaceutica Sinica B · 2026 · Same journal
• A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer · Acta Pharmaceutica Sinica B · 2026 · Same journal